Gastroesophageal reflux disease
MONDO:0007186A chronic disorder characterized by reflux of the gastric and/or duodenal contents into the distal esophagus. It is usually caused by incompetence of the lower esophageal sphincter. Symptoms include heartburn and acid indigestion. It may cause injury to the esophageal mucosa.
Also known as: GERD, acid reflux, gastroesophageal reflux, gastroesophageal reflux disease, gastroesophageal reflux, paediatric, gastroesophageal reflux, pediatric, ger
185 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
New study pits tiny valve fix against major surgery for heart valve failure
Disease control CompletedThis study compared two ways to fix a failed mitral heart valve replacement: a less invasive procedure called valve-in-valve (using a catheter to place a new valve inside the old one) versus repeat open-heart surgery. The trial included 150 adults with severe valve problems. Rese…
Phase: NA • Sponsor: Instituto Dante Pazzanese de Cardiologia • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Keyhole surgery offers relief for hidden hiatal hernia sufferers
Disease control CompletedThis study looked at whether a specific keyhole surgery (Toupet fundoplication) can help people with a hiatal hernia that causes heartburn but doesn't show up on X-rays. 100 adults with this condition had the surgery and were followed to see if their symptoms came back or if they…
Phase: NA • Sponsor: Minia University • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New surgical tweak may cut acid reflux after gastric sleeve
Disease control CompletedThis study tested whether adding a crural repair and gastropexy to standard sleeve gastrectomy reduces acid reflux in people with severe obesity. Fifty patients were randomly assigned to either the standard surgery or the enhanced version. After one year, the group with the extra…
Phase: NA • Sponsor: Van Training and Research Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New surgical stapler tested in GERD study shows promise
Disease control CompletedThis study tested a special stapler during a combined weight-loss and anti-reflux surgery called Nissen Sleeve. It involved 167 people with obesity and GERD. The goal was to see if the surgery reduces acid reflux and if the stapler works safely.
Phase: NA • Sponsor: Ezisurg Medical Co. Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Simple drug may cut infection risk after major gut surgery
Disease control CompletedThis study tested whether tranexamic acid, a drug that helps blood clot, can lower the chance of infection after gastrointestinal surgery. Over 3,300 adults at higher risk for complications took part. The goal was to see if the drug reduces surgical site infections compared to a …
Phase: PHASE4 • Sponsor: Bayside Health • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New drug combo targets brain to soothe stubborn reflux
Disease control CompletedThis study tested whether adding a gut-brain neuromodulator (Flupentixol-Melitracen) to standard acid-reducing therapy (Lansoprazole) helps people with gastroesophageal reflux disease (GERD) who still have symptoms on acid suppressants alone. The trial enrolled 164 adults with GE…
Phase: NA • Sponsor: RenJi Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Barrett's esophagus treatment showdown: which procedure hurts less?
Disease control CompletedThis study compared two endoscopic treatments for Barrett's esophagus, a condition that can lead to esophageal cancer. The goal was to see which procedure—radiofrequency ablation or hybrid argon plasma coagulation—causes less pain and is safer from the patient's viewpoint. Sixty-…
Phase: NA • Sponsor: Centre of Postgraduate Medical Education • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New heart valve fix without open surgery shows promise in High-Risk patients
Disease control CompletedThis study tested a new device called the Tiara valve, which is implanted through a small tube in the chest to replace the leaky mitral valve without open-heart surgery. It enrolled 157 people with severe mitral regurgitation who were considered too high-risk for traditional surg…
Phase: NA • Sponsor: Shockwave Medical, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New catheter device aims to fix leaky heart valve without cutting chest
Disease control CompletedThis early study tested a device called the Edwards PASCAL system, which is threaded through a blood vessel to repair the tricuspid valve in the heart. The valve can leak, causing symptoms like shortness of breath and swelling. The study included 65 people with severe leakage who…
Phase: NA • Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
GERD drug BLI5100 passes Year-Long safety check
Disease control CompletedThis study checked the safety of taking BLI5100 daily for up to 12 months in 400 adults with gastroesophageal reflux disease (GERD). Participants had either non-erosive reflux disease or healed erosive esophagitis. The main goal was to track any side effects. This is a disease co…
Phase: PHASE3 • Sponsor: Braintree Laboratories • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Gene-Guided reflux drug may tame childhood asthma
Disease control CompletedThis study tested whether adjusting the dose of a common acid reflux medicine (lansoprazole) based on a child's genes could improve asthma control. 41 children aged 6-17 with uncontrolled asthma and mild reflux participated. Researchers measured changes in asthma symptoms and ref…
Phase: PHASE3 • Sponsor: Jason Lang, M.D., M.P.H. • Aim: Disease control
Last updated Jun 26, 2026 15:11 UTC
-
No more tubes? swallowable capsule could revolutionize stomach acid testing
Diagnosis CompletedThis study tests a new, less invasive way to measure stomach acid using a small wireless capsule (SmartPill) that patients swallow. It compares the capsule's accuracy to the standard method, which involves a tube placed through the nose into the stomach. The study includes health…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Diagnosis
Last updated Jul 04, 2026 00:00 UTC
-
One-Minute test could replace painful GERD diagnostics
Diagnosis CompletedThis study tested a new, faster way to diagnose GERD (heartburn disease) using a special probe during a routine endoscopy. The test takes only one minute and may be more comfortable than current methods. Fifteen adults with known reflux participated, and their results were compar…
Phase: NA • Sponsor: Vanderbilt University Medical Center • Aim: Diagnosis
Last updated Jun 27, 2026 12:37 UTC
-
Heartburn relief in a pill? PepZinGI put to the test
Symptom relief CompletedThis study tested whether PepZinGI, a zinc-L-carnosine supplement, can reduce heartburn triggered by food. Fifty adults with frequent heartburn completed two one-week treatment periods (PepZinGI and placebo) remotely, using wearable devices and surveys to track symptoms and sleep…
Phase: NA • Sponsor: NutriScience Innovations, LLC • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Could a simple swaddle ease dangerous reflux in preemies?
Symptom relief CompletedThis study looked at whether a swaddle blanket with a gentle abdominal band can reduce acid reflux, breathing pauses, heart rate drops, and low oxygen levels in premature infants. About 50 babies in the NICU were observed to see if the blanket helped. The goal was to find a simpl…
Phase: NA • Sponsor: Valley Health System • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
Diet change may soothe stubborn heartburn when pills fail
Symptom relief CompletedThis study tested whether a low-FODMAP diet could help people with gastro-esophageal reflux disease (GERD) whose symptoms persist despite taking standard acid-reducing drugs (PPIs). Thirty-one adults with confirmed reflux were randomly assigned to either a low-FODMAP diet or a st…
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
Can an online wellness program ease anxiety in chronic disease?
Symptom relief CompletedThis study tested a 12-week online mind-body program for adults with chronic conditions like heart failure, cancer, and liver disease. The program included mindful movement, meditation, breathwork, and coping skills. Researchers measured changes in anxiety, depression, fatigue, a…
Phase: NA • Sponsor: University of Alberta • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
Pilates may ease acid reflux without pills
Symptom relief CompletedThis study tested whether six weeks of supervised Pilates exercises could reduce symptoms of gastroesophageal reflux disease (GERD) in 33 adults. Participants did 18 sessions of posture-focused Pilates or continued their usual daily activities. Researchers measured changes in ref…
Phase: NA • Sponsor: Istinye University • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
Could a zinc supplement soothe baby reflux?
Symptom relief CompletedThis study tested whether Polaprezinc (Zinc-L carnosine) can reduce reflux symptoms in infants aged 1-12 months. Sixty babies were given either the supplement or a thickened formula twice daily for 8 weeks. Researchers measured changes in a reflux symptom questionnaire to see if …
Phase: NA • Sponsor: University of Roma La Sapienza • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
New syrup shows promise for soothing stubborn heartburn
Symptom relief CompletedThis study tested a new syrup, called Fibroin Syrup, to see if it is safe and can help reduce symptoms of gastroesophageal reflux disease (GERD), like heartburn and regurgitation. The study included 47 adults with non-erosive reflux disease (NERD) who had symptoms for at least 8 …
Phase: NA • Sponsor: Rose Pharma SA • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Which GERD drug works better? new study compares two popular options
Symptom relief CompletedThis study compared two medications, esomeprazole and vonoprazan, for treating gastroesophageal reflux disease (GERD). Researchers enrolled 824 adults aged 18 to 65 with GERD and measured how many achieved sufficient symptom relief. The goal was to find which drug works better fo…
Phase: NA • Sponsor: Muhammad Aamir Latif • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
New hope for preventing Post-Surgery confusion in seniors
Symptom relief CompletedThis study tested whether giving a small amount of s-ketamine during chest surgery could reduce the risk of postoperative delirium (sudden confusion) in patients aged 60 and older. Over 500 participants were randomly assigned to receive either s-ketamine or another drug (dexmedet…
Phase: EARLY_PHASE1 • Sponsor: Affiliated Cancer Hospital & Institute of Guangzhou Medical University • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
Which GERD syrup works best? new study pits alginate against sucralfate
Symptom relief CompletedThis study tested whether alginate (Gaviscon) or sucralfate (Ulsanic) provides better symptom relief for people with GERD who are already taking acid-reducing medication (PPIs). 140 adults with frequent severe heartburn took one of the two syrups before meals. Researchers measure…
Phase: PHASE2, PHASE3 • Sponsor: CMH Lahore Medical College and Institute of Dentistry • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
New heartburn drug put to the test – with and without food
Symptom relief CompletedThis early-stage trial tested a new drug called DW4421 in 24 healthy adults to see how food changes the way the body absorbs it. The goal is to learn whether the drug should be taken with or without food for future studies. This is a safety and dosing study, not a test of whether…
Phase: PHASE1 • Sponsor: Daewon Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
New GERD drug fexuprazan tested against standard treatment in 145 patients
Symptom relief CompletedThis study tested whether fexuprazan, a new drug, can relieve heartburn and acid reflux as well as the commonly used esomeprazole. 145 adults with GERD took either fexuprazan or esomeprazole once daily for 4 weeks, with an option to continue for another 4 weeks if symptoms didn't…
Phase: PHASE3 • Sponsor: Indonesia University • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
Hypnosis for your stomach? tiny study tests Gut-Directed therapy online
Symptom relief CompletedThis study tested whether gut-directed hypnotherapy (GDH) delivered via telehealth could help manage gastrointestinal symptoms in adults with disorders of gut-brain interaction. Eleven participants completed sessions of general relaxation hypnosis and GDH, plus a 3-month follow-u…
Phase: NA • Sponsor: University of Central Florida • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
New supplement shows promise for soothing heartburn
Symptom relief CompletedThis study tested whether a liquid dietary supplement called Anvitra Gastric Suspension can reduce heartburn, regurgitation, and indigestion in people with GERD. Twenty-seven adults took the supplement three times daily for 14 days. Researchers measured symptom changes using a st…
Phase: NA • Sponsor: Haiphong University of Medicine and Pharmacy • Aim: Symptom relief
Last updated Jun 26, 2026 17:08 UTC
-
New GERD drug FEXUCLUE shows promise for heartburn relief
Symptom relief CompletedThis completed study looked at whether FEXUCLUE (fexuprazan) tablets can improve heartburn and acid reflux symptoms in people with erosive gastroesophageal reflux disease (GERD). Over 2,800 adults took the medication for 4 to 8 weeks and reported their symptom changes. The goal w…
Sponsor: Daewoong Pharmaceutical Co. LTD. • Aim: Symptom relief
Last updated Jun 26, 2026 14:11 UTC
-
New drug X842 tested in healthy people for first time
Knowledge-focused CompletedThis early-phase trial tested the safety and tolerability of a drug called X842 in 39 healthy adults. Participants received either single or multiple doses of X842 to see how the body handles it and what side effects may occur. The study is complete and does not aim to treat any …
Phase: EARLY_PHASE1 • Sponsor: Cinclus Pharma Holding AB • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Could stomach surgery raise cancer risk? new study investigates
Knowledge-focused CompletedThis study looked at 100 patients who had sleeve gastrectomy for severe obesity. Researchers checked how many developed Barrett's esophagus, a condition that can lead to esophageal cancer, five or more years after surgery. They also examined whether routine endoscopy (a camera te…
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
500 patient records reviewed to see how pancreatic cancer treatments worked
Knowledge-focused CompletedThis study reviewed medical records of 500 adults treated for benign or malignant pancreatic and stomach diseases from 2005 onward. Researchers looked at overall survival after various treatments. The goal was to understand real-world outcomes, not to test a new drug or procedure…
Sponsor: Methodist Health System • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
Kids' obesity may change how acid reflux drugs work
Knowledge-focused CompletedThis study looked at how obesity affects the way children's bodies process common acid reflux medications like lansoprazole and pantoprazole. Researchers gave a single dose of these drugs to 76 children aged 6-21, both with and without obesity, and measured how long the drugs sta…
Phase: PHASE4 • Sponsor: Children's Mercy Hospital Kansas City • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC
-
AI spots hidden heart valve risks in routine scans
Knowledge-focused CompletedThis completed study used artificial intelligence to analyze electrocardiograms (ECGs) and chest X-rays from over 116,000 adults. The goal was to see if combining these routine tests could predict which patients would develop moderate or severe heart valve regurgitation. The rese…
Sponsor: Shanghai Zhongshan Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Breathing exercises may strengthen key muscle for reflux sufferers
Knowledge-focused CompletedThis study looked at 13 people undergoing a standard esophagus pressure test to see which breathing positions or maneuvers create the highest pressure at the junction between the esophagus and stomach. The goal is to learn how to better contract the diaphragm, which may help with…
Phase: NA • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
Routine stomach checks may be unnecessary for ventilated patients
Knowledge-focused CompletedThis study looked at whether routinely measuring leftover stomach volume in patients on breathing machines and feeding tubes helps prevent pneumonia. Researchers compared patients who had these checks every six hours to those who did not. The goal was to see if skipping the check…
Phase: NA • Sponsor: Centre Hospitalier Departemental Vendee • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC
-
Can constipation drugs reveal hidden signals in gut tissue?
Knowledge-focused CompletedThis early study looked at how two approved constipation drugs, plecanatide and linaclotide, affect a chemical called cGMP in the small intestine. Researchers compared tissue samples from 43 adults with Barrett esophagus or GERD who took either drug or no drug. The goal was to me…
Phase: PHASE1 • Sponsor: University of Wisconsin, Madison • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC
-
Xiamen study reveals hidden GERD risks
Knowledge-focused CompletedThis study looked at how many people in Xiamen have gastroesophageal reflux disease (GERD) and what factors might increase their risk. Researchers surveyed 1625 adults who had typical reflux symptoms like heartburn. The goal was to better understand the disease's impact and help …
Sponsor: Zhongshan Hospital (Xiamen), Fudan University • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
Massive study probes cancer risk in EoE patients
Knowledge-focused CompletedThis completed study looked at 100,000 patient records to find out if people with eosinophilic esophagitis (EoE) are more likely to develop esophageal cancer. The researchers wanted to see if any increased risk is due to EoE itself or to other conditions like acid reflux or Barre…
Sponsor: IRCCS San Raffaele • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
12 healthy volunteers test drug combo in Early-Stage study
Knowledge-focused CompletedThis early-stage study looked at how a new GERD drug, linaprazan glurate, changes the way the body processes the antibiotic amoxicillin. Twelve healthy adults took amoxicillin alone and then again after a week of the GERD drug. The goal was to measure drug levels in the blood, no…
Phase: PHASE1 • Sponsor: Cinclus Pharma Holding AB • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
Tulip-Shaped airway may lower reflux risk during surgery
Knowledge-focused CompletedThis study tested two types of glottis mask airways (a tube placed in the throat to help patients breathe during anesthesia) to see which one reduces the risk of stomach acid backing up into the throat. The tulip-shaped tip is designed to fit the larynx better than the classical …
Phase: NA • Sponsor: Air Force Military Medical University, China • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC
-
Cough-Counting app tested in 616 patients
Knowledge-focused CompletedThis study tested a smartphone app called Hyfe Cough Tracker to see if it can accurately count coughs in people with lung conditions like COPD, asthma, or COVID-19. Researchers compared the app's cough counts to patients' own reports and expert listening. The goal was to improve …
Sponsor: Clinica Universidad de Navarra, Universidad de Navarra • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC
-
Survey aims to uncover hidden barriers to esophageal cancer screening
Knowledge-focused CompletedThis completed study surveyed over 700 primary care doctors, gastroenterologists, and patients across seven U.S. health systems. The goal was to find out what knowledge gaps, attitudes, and practical barriers prevent people from getting screened for Barrett's esophagus, a conditi…
Sponsor: University of Colorado, Denver • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC